One in 10 clinics in SA — across 22 health districts in six provinces — could start to hand out a twice-a-year anti-HIV jab ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 22, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the “Company”), announced that its clinical lead drug NV-387 has shown ...
Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback